Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials
Journal of Clinical Oncology · 01.08.2026 · 44 (22) · 2071-2074
DOI: 10.1200/jco-26-00383 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.08.2026. Verfasst von Anju Nohria und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Brigham and Women's Hospital, Boston, MA. Die Arbeit nennt 11 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Cardiovascular Division, Brigham and Women's Hospital, Boston, MA.
- Adult Medical Oncology, Dana Farber Cancer Institute, Boston, MA.
ORCID-Profile: Ann S LaCasce
Zitieren
APA
Nohria, A., & LaCasce, A. S. (2026). Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials. Journal of Clinical Oncology, 44(22), 2071-2074. https://doi.org/10.1200/jco-26-00383
Vancouver
Nohria A, LaCasce AS. Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials. Journal of Clinical Oncology. 2026;44(22):2071-2074. doi:10.1200/jco-26-00383
BibTeX
@article{Nohria2026,
author = {Nohria, Anju and LaCasce, Ann S},
title = {Rethinking Cardiovascular Events, End Points, and Surveillance in Oncology Trials},
journal = {Journal of Clinical Oncology},
year = {2026},
volume = {44},
number = {22},
pages = {2071--2074},
doi = {10.1200/jco-26-00383}
}
EUVIMED